S. 1096: Preserve Access to Affordable Generics and Biosimilars Act

S. 1096 is a federal bill in the 119th Congress. Today, brand-name pharmaceutical companies sometimes pay generic drug manufacturers to delay releasing cheaper versions of medications, which keeps prices high for consumers. Under this bill, these types of payment agreements are presumed to be illegal,… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.